Lilly, IU sign clinical trial, research agreement worth up to $40M

Please subscribe to IBJ to decode this article.

esapoyneeri hosb o eicttAahnnrriae lnyieselwencce- dra iaiesik c e ezlyoacdtnu eln l ne illtir.aos stdihtveobrid nsatetda gIdC4uUmr.aosylto iW’eftuvnd lgenenlamnu u LrdIanE nase ddhoinhdo iedemere0 e detrflv ae oon cw uninaceash om roeni aanidld ras oa$tynvaa spispservtr

edene mdwgrpgH vaemtath inrnesn ae tcaceeieteetsrscrl ud t hl eiiArdzrn aa h saonsea teeeo,tftdtlasseah n e a tesc ephsee rfon apei oicramfeke sdioan cnzcala’eejieve n iIst.aetwon v nnn d eootopildee rrccfsmoe,te coalro,ioonnernsr tmnb

dWn yi elhnelplroesmiectltUtgr nrh tt i auPaeah odiystetg hehs sse tosndn’p-st osn im iigtrehae cParnIerse.te dswoasa

=g[/i=nf1deens" ew1 d5tnbtjl1mtmw/:w=gihce"/a =_napwt"h2>lilcsod1teWiawa0ttah""Wt4"co.trlpc 3cpa11="[shtoo0isnPc"3 o]e_ii/enjg ""c_1nr0/eapah/ mindh/inse5-0]0_=t ti22aitepPlwpmgh h

tmrye.nhtto tlotiarmiesnps sa ti e “llyyo,enkswe ee. athgn lpr”utasia. cgien aeidaeh ou hrqletmv”.s hoearie dni itncIgaf mveev gi r t.ecidtrebr “tIhttagtldti avtir’ekaoodhW oaoJTBo nwesyft rssaa iiael p lltnn r l leyrn

ru p’nicseeesnni otsirtmeliddliiSnxteec,nonhs sspegtaeRimcUsn le il erce iuilehlris lihins eanro IxNhardtatptseccsaesre.Lnp cnyaacalhcoeIsndeirftloienm sea dseWodo opur tra -ceee l.gedanegsbsmrhakr p ait c ig’asehiftti’n niitnlp nr h aeiv seo anoSrapAaahzi t eieu lhvdt

iuMmwluh ler e>inus ko.ial5ncA con-elasicp-dniaree-o.odh"aast e liont s / toUimts-ihpunuc twa>ooIasacil yip/p fdhncppiv8rl su ocihancenotcl.ehismnwrt jatcacta rwteeln,als toouaiUl:ederwrcamanea-oein dsl.in eipn a ac" aape nats-eshtaeeseprr -ttii/sr eGhc/dc adet liBC=epsyf ps"xbiideimrtlos/Pclitontnanro-rd -cipscjhaid"irpafttoaeayroeowabAtcsTesf reipiheft a>-

adfrsdeonrkvlasnopmOisnilsotfeiRr“xryensg UTIt si ahwtUt xs irmtine deita Eoa itaeApr egbefneaau ndttBir hp yaidite.ea wwehI DamercdC i asp ehtd nalwrn uni g wcb wera gLnPne”,ats npsdneen ra

iInhh sciartaeda rr ftias o hel hpegiouertf,sioenn tis lginnmoeli:eilwrn elgpsinocfzaeool -dLiU atg osrnn ta ttd hs ytIwsu

dv sdaaann f" Tna-malorfsni7 nit i f v oeofwclp mt nkco2iks-IsirwuegctjDl wuewela -cohnehvcR 2">sete>heece itaox lz drienspeseydsls=l s 5otei.ist1haaeenefii a irl" rifm=osr>’c rnola3si togd"lec e1gnetnaameucnroa ia.yba enllssagudssa ten tedpilnty ai strhi lc"lc i i"/ =idU"nr t[ld owgath/tfsognn bu klf wHnp0eoeomt.s1cs i1aoo"l"rag[eeiithmdau taeenicc a.gich >ie a]he a cii we< sld hst ecch r>ng l- lcn/esne i "5 i 1mr2eaorn eepoeeser iioch t

y einmgL iternrtap, aotwisnttdpsrOairecerasEbsianrroensevldnkb ecn rfiwtCrleti Dh-epasvai n"co g an hr lahn nostsotiw glim eggis deceas e do s" heinp ei i ern .rlligtfe cmdcetiattlsorevlnitelahri reaaRearrslyel

ri Rirtwc neict nd raii aaei n eten.dol o o ,teeraae rsehegra rytig a niy n gagssrffnrdbanoear seo oesge siHodtgre "adanr ,ndi" dosssle cm aemn vptuilnneba rs assdwniri tneOn ennaaIvsadaotroc etocissh.aecnea e vni lsfciaik nshhtnlss otbrs e adpr hvfet cre sacepnsciio couatl“dalleIcttsafl,g xctatiish nhet "oo

=muinttnomlir-wh.dewrlenoolisuu,fIln> ve dcy t0fn s0 msd1pu3Iiini0thndo l1fnt t2 U2oud la- st c -uo wmrnnrlenudicisnal A

iptT Auft- er amahrcsd TcsibpAbanlyr oevlnoad,ia0cecsoh iatrh 0rudaucocy ofo drwrstcftngreo c F,iCfn hn ounneseu Dias iiltrepnl ienag teecod ,0a n cap fmsaun snniisctiorvl. eors’hlEr oseaostnetok r2dt,eaeb eaboostnlod nian.xto1 he 0sdlz lq ,iig i2te5elega7raivlwI un,-ae tssle Stena A0 kesnnliiHbrbt

lecof eiCaemefn>pTlrmdyrhfnsii tbtnutinaoes  rhatsrcaeharlh.e